SoCal's Vical Terminates 54% of Workforce to Focus Resources on Two Clinical Programs Post author:Sam Post published:January 30, 2018 Post category:BioPharma Vical announced its restructuring late Tuesday. Source: BioSpace You Might Also Like Pfizer Quietly Kills 3 Pipeline Programs January 30, 2017 SoCal's Artelo Biosciences Inks $202M+ R&D Deal With the NEOMED Institute January 29, 2018 Biogen To Present Data At July 13, 2017
